| Results summary | View all lists in L2L MDB | View all genes in D01AC.profile.d50 |
|
Down-regulated in human hepatoma cells (HepG2) following 24 hrs treatment with 2.5 microM 5-aza-2-deoxycytidine (5azaC) and 24 hrs treatment with both 5azaC and 500 nM trichostatin A (TSA). enrichment: 1.73-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 212214_AT | OPA1 | G | T | optic atrophy 1 (autosomal dominant) | |||||||||
| 201016_AT | EIF1AX | P | eukaryotic translation initiation factor 1A, X-linked | ||||||||||
| 221196_X_AT | BRCC3 | X | P | BRCA1/BRCA2-containing complex, subunit 3 | |||||||||
| 212825_AT | PAXIP1 | PAX interacting (with transcription-activation domain) protein 1 | |||||||||||
| 203347_S_AT | MTF2 | metal response element binding transcription factor 2 | |||||||||||
| 212030_AT | RBM25 | R | RNA binding motif protein 25 | ||||||||||
| 212023_S_AT | MKI67 | G | antigen identified by monoclonal antibody Ki-67 | ||||||||||
| 214314_S_AT | EIF5B | P | eukaryotic translation initiation factor 5B | ||||||||||
| 215731_S_AT | MPHOSPH9 | M-phase phosphoprotein 9 | |||||||||||
| 201585_S_AT | SFPQ | X | R | splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated) | |||||||||